Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16367360 | 0.86 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1PKMTAAR1MITF | |
| SCHEMBL16367313 | 0.83 | L3MBTL1 (0.39) | L3MBTL1ALDH1A1PKMTAAR1SMN1; SMN2 | |
| SCHEMBL16367345 | 0.79 | L3MBTL1 (0.38) | L3MBTL1ALDH1A1PKMTAAR1SMN1; SMN2 | |
| SCHEMBL16367393 | 0.78 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1PKMTAAR1HIF1A | |
| SCHEMBL15607863 | 0.77 | L3MBTL1 (0.45) | L3MBTL1ALDH1A1PKMTAAR1SMN1; SMN2 | |
| SCHEMBL9873776 | 0.75 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1PKMTAAR1MITF | |
| SCHEMBL28807491 | 0.75 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1PKMTAAR1SMN1; SMN2 | |
| SCHEMBL24728704 | 0.74 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1PKMTAAR1SMN1; SMN2 | |
| SCHEMBL27727096 | 0.74 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1PKMTAAR1SMN1; SMN2 | |
| SCHEMBL19698979 | 0.73 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1PKMTAAR1MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150010474-A1 | Compounds And Methods For Selective Imaging And/Or Ablation | AUCKLAND UNISERVICES LTD (NL) | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150010474-A1 | Compounds And Methods For Selective Imaging And/Or Ablation | CBR1, CBR3, BLVRB | L3MBTL1 2029/4885ALDH1A1 140/4885PKM 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.